Inventor · disambiguated record
Rango Dietrich
Also filed as: DIETRICH RANGO
30 granted patents·13 pending applications·893 citations·filing 1992–2015
98Inventor score
Top patents by PatentIndex Score
43 records- 0196US7951398B2Pharmaceutical preparation comprising an active dispersed on a matrixNYCOMED GMBH·Filed 2006·Granted May 31, 2011·50 cites·20 claims
- 0295US6569453B2Administration form comprising an acid-labile active compoundALTANA PHARMA AG·Filed 2001·Granted May 27, 2003·57 cites·40 claims
- 0395US6274173B1Oral pharmaceutical composition with delayed release of active ingredient for pantoprazoleBYK GULDEN LOMBERG CHEM FAB·Filed 1999·Granted Aug 14, 2001·107 cites·17 claims
- 0494US7785630B2Preparation and administration form comprising an acid-labile active compoundNYCOMED GMBH·Filed 2007·Granted Aug 31, 2010·10 cites·18 claims
- 0593US6328993B1Oral administration form for an acid liable active proton pump inhibitorBYK GULDEN LOMBERG CHEM FAB·Filed 1998·Granted Dec 11, 2001·86 cites·37 claims
- 0692US7790198B2Preparation and administration form comprising an acid-labile active compoundNYCOMED GMBH·Filed 2006·Granted Sep 7, 2010·8 cites·16 claims
- 0792US6383510B1Suppository form comprising an acid-labile active compoundBYK GULDEN LOMBERG CHEM FAB·Filed 1998·Granted May 7, 2002·69 cites·29 claims
- 0891US5945124AOral pharmaceutical composition with delayed release of active ingredient for pantoprazoleBYK GULDEN LOMBERG CHEM FAB·Filed 1995·Granted Aug 31, 1999·77 cites·15 claims
- 0989US7175854B2Pharmaceutical preparation comprising an active dispersed on a matrixALTANA PHARMA AG·Filed 2001·Granted Feb 13, 2007·30 cites·14 claims
- 1089US6132768AOral pharmaceutical composition with delayed release of active ingredient for reversible proton pump inhibitorsBYK GULDEN LOMBERG CHEM FAB·Filed 1995·Granted Oct 17, 2000·92 cites·18 claims
- 1189US5997903AOral-administration forms of a medicament containing pantoprazolBYK GULDEN LOMBERG CHEM FAB·Filed 1992·Granted Dec 7, 1999·103 cites·11 claims
- 1288US7147869B2Rapidly disintegrating tablet comprising an acid-labile active ingredientALTANA PHARMA AG·Filed 2001·Granted Dec 12, 2006·33 cites·14 claims
- 1387US6068856AOral pharmaceutical composition with delayed release of active ingredient for pantoprazoleBYK GULDEN LOMBERG CHEM FAB·Filed 1998·Granted May 30, 2000·54 cites·16 claims
- 1486US7951397B2Oral dosage form containing a PDE 4 inhibitor as an active ingredient and polyvinylpyrrolidon as excipientNYCOMED GMBH·Filed 2003·Granted May 31, 2011·13 cites·33 claims
- 1585US8431154B2Oral dosage form containing a PDE 4 inhibitor as an active ingredient and polyvinylpyrrolidone as excipientDIETRICH RANGO·Filed 2011·Granted Apr 30, 2013·5 cites·38 claims
- 1684US6780881B2Freeze-dried pantoprazole preparation and pantoprazole injectionALTANA PHARMA AG·Filed 2002·Granted Aug 24, 2004·14 cites·24 claims
- 1783US7794752B1Preparation and administration form comprising an acid-labile active compoundNYCOMED GMBH·Filed 2000·Granted Sep 14, 2010·10 cites·19 claims
- 1883US7357943B2Pharmaceutical preparation in the form of a suspension comprising an acid-labile active ingredientNYCOMED GMBH·Filed 2001·Granted Apr 15, 2008·13 cites·23 claims
- 1982US6607742B2Suppository composition which is a spray-dried suspension of an acid-labile proton pump inhibitor in a solvent solution of a sterol and polymerALTANA PHARMA AG·Filed 2002·Granted Aug 19, 2003·10 cites·32 claims
- 2081US7351723B2Freeze-dried pantoprazole preparation and pantoprazole injectionNYCOMED GMBH·Filed 2004·Granted Apr 1, 2008·10 cites·14 claims
- 2177USD620976SBinderDIETRICH RANGO·Filed 2008·Granted Aug 3, 2010·22 cites·1 claims
- 2273US7988999B2Pharmaceutical preparation in the form of a paste comprising an acid-labile active ingredientNYCOMED GMBH·Filed 2001·Granted Aug 2, 2011·6 cites·18 claims
- 2372US6884437B2Administration form comprising an acid-labile active compoundBYK GULDEN LOMBERG CHEM FAB·Filed 2003·Granted Apr 26, 2005·3 cites·12 claims
- 2467US7402321B2Oral administration form for pyridin-2-ylmethylsulfinyl-1H-benzimidazolesNYCOMED GMBH·Filed 2006·Granted Jul 22, 2008·0 cites·30 claims
- 2566US9468598B2Oral dosage form containing a PDE 4 inhibitor as an active ingredient and polyvinylpyrrolidon as excipientASTRAZENECA AB·Filed 2013·Granted Oct 18, 2016·0 cites·41 claims
- 2665US2014031396A1Oral Dosage Form Containing A Pde 4 Inhibitor As An Active Ingredient And Polyvinylpyrrolidon As ExcipientTAKEDA GMBH·Filed 2013·Application pending·0 cites
- 2765US2014031397A1Oral Dosage Form Containing A Pde 4 Inhibitor As An Active Ingredient And Polyvinylpyrrolidon As ExcipientTAKEDA GMBH·Filed 2013·Application pending·0 cites
- 2863US8465767B2Oral administration form for pyridin-2-ylmethylsulfinyl-1H benzimidazolesDIETRICH RANGO·Filed 2008·Granted Jun 18, 2013·0 cites·21 claims
- 2963US2006269600A1Oral dosage form containing a PDE 4 inhibitor as an active ingredient and polyvinylpyrrolidon as excipientALTANA PHARMA AG·Filed 2006·Application pending·0 cites
- 3063US2013131123A1Oral Dosage Form Containing A Pde 4 Inhibitor As An Active Ingredient And Polyvinylpyrrolidon As ExcipientDIETRICH RANGO·Filed 2013·Application pending·0 cites
- 3162US8754108B2Freeze-dried pantoprazole preparation and pantoprazole injectionLINDER RUDOLF·Filed 2008·Granted Jun 17, 2014·0 cites·16 claims
- 3260US2015290179A1Oral Dosage Form Containing A PDE 4 Inhibitor as an Active Ingredient and Polyvinylpyrrolidon as ExcipientTAKEDA GMBH·Filed 2015·Application pending·0 cites
- 3360US2015290180A1Oral Dosage Form Containing A PDE 4 Inhibitor as an Active Ingredient and Polyvinylpyrrolidon as ExcipientTAKEDA GMBH·Filed 2015·Application pending·0 cites
- 3460US2015290178A1Oral Dosage Form Containing A PDE 4 Inhibitor as an Active Ingredient and Polyvinylpyrrolidon as ExcipientTAKEDA GMBH·Filed 2015·Application pending·0 cites
- 3559US7041313B1Oral administration form for pyridin-2-ylmethylsulfinyl-1H-benzimidazolesALTANA PHARMA AG·Filed 1999·Granted May 9, 2006·11 cites·36 claims
- 3659US2011060016A1Oral dosage form containing a pde 4 inhibitor as an active ingredient and polyvinylpyrrolidon as excipientNYCOMED GMBH·Filed 2010·Application pending·0 cites
- 3754US2008257339A1Aerosol ContainerNYCOMED GMBH·Filed 2006·Application pending·0 cites
- 3851US8703192B2Dosage form containing pantoprazole as active ingredientANSTETT-KLEIN ISABEL·Filed 2009·Granted Apr 22, 2014·0 cites·9 claims
- 3950US2009134211A1MethodNYCOMED GMBH·Filed 2006·Application pending·0 cites
- 4049US2009020442A1Method for the Provision of Clinical Trial ProductsNYCOMED GMBH·Filed 2006·Application pending·0 cites
- 4144US8758817B2Dosage form containing (S)-pantoprazole as active ingredientDIETRICH RANGO·Filed 2011·Granted Jun 24, 2014·0 cites·11 claims
- 4243US2006216346A1Dosage form containing (s)-pantoprazole as active ingredientALTANA PHARMA·Filed 2004·Application pending·0 cites
- 4341US2006204568A1Oral pharmaceutical preparation for proton pump antagonistsDIETRICH RANGO·Filed 2004·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Rango Dietrich files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →